Symptoms that prompted the University of Oxford and partner AstraZeneca to pause trials evaluating their experimental coronavirus vaccine probably weren't related to the shot itself, according to documents sent to participants.including limb weakness or "changed sensation", a participant information sheet posted online by Oxford shows.
"In each of these cases, after considering the information, the independent reviewers recommended that vaccinations should continue."Questions have surrounded a UK volunteer's illness in the trial and the safety data that triggered the halt. The Oxford-AstraZeneca vaccine study remains on hold in the US pending a regulatory review, federal officials said.
The interruption highlights the uncertainties researchers face on the road to developing a vaccine. Although temporary halts in such trials aren't uncommon, the pause in the Oxford study has heightened worries about when the first shots providing protection against the pandemic could be ready.
Probably.....
“Probably” “Unlikely” if only science could be more sciency.